Eminent Clinician and Scientist in Oncology, Hematology, and Regenerative Medicine, David K. Jin, MD, PhD, Inducted …

New York, New York (PRWEB) January 16, 2015

The Leading Physicians of the World and the International Association of HealthCare Professionals are proud to announce that David K. Jin, MD, PhD, is being honored for his exceptional successes as a clinical-scientist in oncology, hematology, and regenerative medicine. Over his many years in practice, Dr. Jin has continued to demonstrate the passion, dedication, and enthusiasm for patient care necessary to be considered a Top Clinician, Scientist, and Researcher in his field.

Dr. Jin is currently the Chief Medical Officer of BioTime Inc. as well as its subsidiary OncoCyte Corporation and BioTime Asia Limited. His passion has been to develop novel products for the treatment and diagnosis based on stem cell-derived technology in order to improve both the quality and length of life of patients. Dr. Jin is a clinician and a scientist dedicated to the fields of oncology, hematology, regenerative medicine, and cancer immunotherapy. His work includes his role in various regulatory agencies internationally as medical reviewers as well as Chief Consultant and Advisor for various biotechnology and pharmaceutical companies regarding hematology, oncology, and stem cell-based technology development. Dr. Jin is also a published author and co-author with more than 80 peer reviewed articles, scientific abstracts, reviews, and book chapters featured in publications such as Nature, Nature Medicine, Cell, PNAH, and JCI. He was formerly affiliated with New York-Presbyterian Hospital-Ansary Stem Cell Institute.

Dr. Jin studied medicine at SUNY Downstate Medical Centers College of Medicine in Brooklyn, New York. Established 140 years ago, the school truly revolutionized medical education in the United States as the first medical school founded within a hospital, making bedside training an integral part of students' education. Upon his graduation in 2000, Dr. Jin pursued further clinical training, including his fellowship in hematology and oncology at NewYork-Presbyterian Hospital, where he subsequently received faculty tenure. The NewYork-Presbyterian Hospital is the teaching hospital for both Cornell and Columbia Universities in the areas of internal medicine, hematology, and clinical oncology. Moreover, Dr. Jin has been senior translational scientist at the Howard Hughes Medical Institute and the Ansary Center for Stem Cell Therapeutics at Cornell. His discovery of the chemokine-driven hemangiocytes (bone marrow-derived CXCR4- and VEGFR1-expressing hematopoietic stem cells) in 2006 has had significant impact on the understanding of stem cell mobilization, angiogenesis, and stem cell niche theory. In 2012, Dr. Jin was honored as Top Chief Medical Officer and has been principle investigator in more than 15 pre-clinical and clinical trials as well as translation researcher in stem biology, cancer, and vascular medicine.

To find out more about Dr. Jin, please visit http://www.biotimeinc.com or http://www.oncocyte.com. Also be sure to look out for his upcoming publication in The Leading Physicians of the World.

To find a Doctor by Specialty and Zip Code, please visit http://www.findatopdoc.com and book your appointment online instantly.

Link:
Eminent Clinician and Scientist in Oncology, Hematology, and Regenerative Medicine, David K. Jin, MD, PhD, Inducted ...